IN8BIO, INC. Deferred Tax Assets, Goodwill and Intangible Assets
IN8BIO, INC. (INAB) had Deferred Tax Assets, Goodwill and Intangible Assets of $5.29 million as of 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets · last filed 2026-03-12
- 2025-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $5.29M.
- 2024-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $6.92M.
- 2023-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $4.95M.
- 2022-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $2.94M.
| Period end | Deferred Tax Assets, Goodwill and Intangible Assets |
|---|---|
| 2025-12-31 | $5.29M 10-K · filed 2026-03-12 |
| 2024-12-31 | $6.92M 10-K · filed 2026-03-12 |
| 2023-12-31 | $4.95M 10-K · filed 2025-03-13 |
| 2022-12-31 | $2.94M 10-K · filed 2024-03-14 |
| 2021-12-31 | $1.92M 10-K · filed 2023-03-30 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B |